GlassScriptPhysician profile
Steven M Popper
NPI 1790302123
$770.51
in general payments reported to CMS, 2019-2025
17 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $48.40 · 2022: $161 · 2023: $212 · 2024: $162 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $167.56 | 2022-2023 | |
| Genentech USA, INC. | $87.50 | 2023-2025 | Itovebi, Venclexta, Phesgo |
| E.R. Squibb & Sons, L.L.C. | $83.20 | 2022-2023 | Eliquis |
| Merck Sharp & Dohme LLC | $69.18 | 2021-2024 | Keytruda, Lynparza |
| Adaptive Biotechnologies Corporation | $57.29 | 2025 | Clonoseq |
| Amgen INC. | $49.18 | 2022-2023 | Vectibix, Xgeva, Nplate |
| Janssen Biotech, INC. | $41.14 | 2025 | Erleada |
| Array Biopharma INC | $32.36 | 2024 | Mektovi, Braftovi, Lorbrena |
| Daiichi Sankyo INC. | $29.65 | 2023 | Enhertu |
| Glaxosmithkline, LLC. | $27.07 | 2025 | Jemperli, Zejula |
| Stemline Therapeutics INC. | $21.26 | 2023 | Orserdu |
| Gilead Sciences, INC. | $20.93 | 2024 | |
| Lilly USA, LLC | $19.81 | 2024 | Verzenio |
| Sobi, INC | $18.02 | 2025 | |
| Janssen Pharmaceuticals, INC | $15.98 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.62 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.76 | 2024 | Fruzaqla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Popper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.